Literature DB >> 24068023

Aortic valve sclerosis in acute coronary syndrome patients : potential value in predicting coronary artery lesion complexity.

L Korkmaz1, E Pelit, H Bektas, M T Ağaç, H Erkan, I Gurbak, Ş Çelik.   

Abstract

OBJECTIVE: The purpose of the present study was to investigate the relation between aortic valve sclerosis (AVS) and coronary artery lesion complexity as assessed using the SYNTAX score (SxScore) in acute coronary syndrome (ACS) patients. PATIENTS AND METHODS: A total of 164 patients with a first time diagnosis of acute coronary syndrome were consecutively enrolled. AVS was defined by echocardiography as thickening and calcification of the normal trileaflet aortic valve without obstruction to the left ventricular outflow. The SxScore was calculated using dedicated computer software.
RESULTS: There were significantly higher SxScores in subjects with AVS than those without AVS (18 ± 6 vs 12 ± 5, p = 0.02). In the univariate analysis, age (p = 0.03) and presence of AVS (p = 0.007) were significantly associated with higher SxScores. Logistic regression analysis demonstrated AVS [95 % confidence interval (CI) 0.17-0.86, p = 0.017] and age (95 % CI 1.01-1.21, p = 0.028) as independent determinants of higher SxScores.
CONCLUSION: Aortic valve sclerosis was significantly and independently associated with a high SxScore in acute coronary syndrome patients.

Entities:  

Mesh:

Year:  2013        PMID: 24068023     DOI: 10.1007/s00059-013-3936-6

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  18 in total

1.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.

Authors:  E M Antman; M Cohen; P J Bernink; C H McCabe; T Horacek; G Papuchis; B Mautner; R Corbalan; D Radley; E Braunwald
Journal:  JAMA       Date:  2000-08-16       Impact factor: 56.272

2.  Aortic valve sclerosis in patients with peripheral and/or coronary arterial disease.

Authors:  Maria-Angela Losi; Gregorio Brevetti; Vittorio Schiano; Giovanni Barbati; Valentina Parisi; Carla Contaldi; Elena Chiacchio; Massimo Cavallaro; Gerardo Carpinella; Angelica Fundaliotis; Lucia-Serena Parrella; Sandro Betocchi; Linda Brevetti; Massimo Chiariello
Journal:  Echocardiography       Date:  2010-04-16       Impact factor: 1.724

3.  Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial.

Authors:  Alexandra J Lansky; Kenji Goto; Ecaterina Cristea; Martin Fahy; Helen Parise; Frederick Feit; E Magnus Ohman; Harvey D White; Karen P Alexander; Michel E Bertrand; Walter Desmet; Martial Hamon; Roxana Mehran; Jeffrey Moses; Martin Leon; Gregg W Stone
Journal:  Circ Cardiovasc Interv       Date:  2010-07-20       Impact factor: 6.546

Review 4.  Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies.

Authors:  Rosario V Freeman; Catherine M Otto
Journal:  Circulation       Date:  2005-06-21       Impact factor: 29.690

5.  Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAXscore study.

Authors:  Michael Magro; Sjoerd Nauta; Cihan Simsek; Yoshinobu Onuma; Scot Garg; Elco van der Heide; Willem J van der Giessen; Eric Boersma; Ron T van Domburg; Robert Jan van Geuns; Patrick W Serruys
Journal:  Am Heart J       Date:  2011-04       Impact factor: 4.749

6.  Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.

Authors:  Scot Garg; Giovanna Sarno; Patrick W Serruys; Alfredo E Rodriguez; Leonardo Bolognese; Maurizio Anselmi; Nicoletta De Cesare; Salvatore Colangelo; Raul Moreno; Stefania Gambetti; Monia Monti; Laura Bristot; Marco Bressers; Hector M Garcia-Garcia; Giovanni Parrinello; Gianluca Campo; Marco Valgimigli
Journal:  JACC Cardiovasc Interv       Date:  2011-01       Impact factor: 11.195

7.  Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial.

Authors:  Joanna J Wykrzykowska; Scot Garg; Chrysafios Girasis; Ton de Vries; Marie-Angele Morel; Gerrit-Anne van Es; Pawel Buszman; Axel Linke; Thomas Ischinger; Volker Klauss; Roberto Corti; Franz Eberli; William Wijns; Marie-Claude Morice; Carlo di Mario; Robert Jan van Geuns; Peter Juni; Stephan Windecker; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2010-07-20       Impact factor: 24.094

8.  Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy.

Authors:  Stephen G Ellis; Derek Chew; Albert Chan; Patrick L Whitlow; Jakob P Schneider; Eric J Topol
Journal:  Circulation       Date:  2002-09-03       Impact factor: 29.690

9.  Assessment of the SYNTAX score in the Syntax study.

Authors:  Patrick W Serruys; Yoshinobu Onuma; Scot Garg; Giovanna Sarno; Marcel van den Brand; Arie-Pieter Kappetein; Nic Van Dyck; Michael Mack; David Holmes; Ted Feldman; Marie-Claude Morice; Antonio Colombo; Eric Bass; Katrin Leadley; Keith D Dawkins; Gerrit-Anne van Es; Marie-Angèle M Morel; Friedrich W Mohr
Journal:  EuroIntervention       Date:  2009-05       Impact factor: 6.534

10.  Aortic valve sclerosis: a marker of significant obstructive coronary artery disease in patients with chest pain?

Authors:  Luca Conte; Andrea Rossi; Mariantonietta Cicoira; Stefano Bonapace; Eleas Alejandra Amado; Giorgio Golia; Piero Zardini; Corrado Vassanelli
Journal:  J Am Soc Echocardiogr       Date:  2007-06       Impact factor: 5.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.